Award-winning study finds antioxidants improve embryo development

Monday, 28 October, 2019

Award-winning study finds antioxidants improve embryo development

A pilot study investigating the role of antioxidants in early embryo development has won the 2019 Best Basic Science Award at the American Society for Reproductive Medicine’s (ASRM) annual congress, one of the world’s largest assisted reproductive technology (ART) meetings.

A combination of three antioxidants — acetyl-L-carnitine (ALC), N-acetyl-L-cysteine (NAC) and α-lipoic acid (ALA) — was added to embryo culture media to see if they had a beneficial effect on resulting embryos. The study assessed 1783 oocytes in different age groups and allocated either the combined antioxidants or standard culture media.

The study found that the presence of antioxidants during IVF and embryo culture significantly increased embryo quality during development in the laboratory, and improved embryo transfer outcomes in patients 35 years and older. The results were presented by Professor David Gardner, Scientific Director at Melbourne IVF and a Distinguished Professor in the School of BioSciences at the University of Melbourne, at ASRM’s 2019 Scientific Congress earlier this month.

“The exciting findings show implantation rates and ongoing pregnancy rates are significantly higher when we used antioxidant-rich culture media in patients with advanced maternal age,” said Prof Gardner.

“The results show supplementation of antioxidants to culture media improve the viability of embryos, plausibly through the reduction of oxidative stress and hence improving clinical outcomes in older women.

“The study adds to a growing body of scientific evidence demonstrating the important role antioxidants are starting to show in improving early embryo development.”

Prof Gardner explained that over the last 30 years he has researched several strategies to protect the embryo during its development in the lab.

“With antioxidants, we have typically focused on one antioxidant at a time. However, more recently we have concentrated on a specific group of antioxidants which work together for greater effect,” he said.

“The benefits of antioxidants are renowned. Antioxidants play a significant role inside our bodies fighting free radicals, but in the laboratory, sperm, eggs and embryos don’t have that luxury.”

Following the results of the pilot study, Prof Gardner is now leading a larger study, a prospective randomised controlled trial (RCT) investigating whether the combination of three antioxidants can play a role in improving the quality of embryos and pregnancy outcome.

The RCT study, available to Melbourne IVF patients who are undergoing IVF or ICSI treatment, has recruited its first 400 patients, with a total patient target of 1200.

Image credit: ©

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Originally published here.

Related News

Over $40m funding for health and medical research projects

Awarded to only the highest-performing researchers of any career stage, NHMRC Investigator Grants...

Award winners announced for 2020 World Metrology Day

20 May was World Metrology Day, celebrating the central role of metrology, or measurement...

Thermo Fisher ramps up response to COVID-19

Serving science company Thermo Fisher Scientific has announced several new measures as part of...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd